TrialRheumatology (Oxford, England)2026

Clinical and molecular data to predict flares in DMARD optimization in rheumatoid arthritis: a randomized, controlled, open-label, non-inferiority trial.

Francisco J Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.